tiprankstipranks
Trending News
More News >
ImageneBio (IMA)
NASDAQ:IMA
US Market

ImageneBio (IMA) Financial Statements

Compare
109 Followers

ImageneBio Financial Overview

ImageneBio's market cap is currently $63.64M. The company's EPS TTM is $; its P/E ratio is -0.74; ImageneBio is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 800.00K$ 3.50M$ 9.16M$ 15.62M$ 30.98M
Gross Profit$ -233.00K$ 3.50M$ 8.14M$ -48.70M$ -16.12M
Operating Income$ -48.45M$ -37.00M$ -75.42M$ -70.90M$ -34.14M
EBITDA$ -47.42M$ -35.47M$ -74.40M$ -70.15M$ -33.59M
Net Income$ -45.35M$ -36.57M$ -68.17M$ -68.77M$ -34.12M
Balance Sheet
Cash & Short-Term Investments$ 75.78M$ 124.39M$ 175.47M$ 156.95M$ 232.22M
Total Assets$ 82.81M$ 141.51M$ 192.09M$ 172.26M$ 247.88M
Total Debt$ 9.99M$ 7.52M$ 10.74M$ 5.69M$ 6.99M
Net Debt$ -24.97M$ -31.87M$ -109.16M$ -54.23M$ -225.23M
Total Liabilities$ 19.84M$ 15.58M$ 22.34M$ 25.29M$ 40.00M
Stockholders' Equity$ 133.14M$ 125.93M$ 169.76M$ 146.97M$ 207.88M
Cash Flow
Free Cash Flow$ -47.84M$ -46.00M$ -80.16M$ -75.54M$ -62.01M
Operating Cash Flow$ -47.84M$ -46.00M$ -79.74M$ -74.11M$ -60.25M
Investing Cash Flow$ -5.81M$ -34.90M$ 64.14M$ -99.28M$ -1.76M
Financing Cash Flow$ 135.47M$ 0.00$ 75.98M$ 1.09M$ 131.74M
Currency in USD

ImageneBio Earnings and Revenue History

ImageneBio Debt to Assets

ImageneBio Cash Flow

ImageneBio Forecast EPS vs Actual EPS